These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27056130)

  • 1. Observations from the recent FDA Circulatory System Devices Panel meeting on bioresorbable vascular scaffolds.
    Serruys PW
    EuroIntervention; 2016 Apr; 11(14):e1569-70. PubMed ID: 27056130
    [No Abstract]   [Full Text] [Related]  

  • 2. So We Have Bioresorbable Scaffolds: Now What?
    King SB
    JACC Cardiovasc Interv; 2016 May; 9(10):1087-8. PubMed ID: 27198690
    [No Abstract]   [Full Text] [Related]  

  • 3. Why Bioresorbable Vascular Scaffold Should Be Approved for Marketing in the United States.
    Waksman R
    Cardiovasc Revasc Med; 2015; 16(7):379-80. PubMed ID: 26573413
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical devices; general and plastic surgery devices; classification of absorbable poly(hydroxybutyrate) surgical suture produced by recombinant DNA technology. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(149):43144-6. PubMed ID: 17682290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix® drug coated balloon.
    Escárcega RO; Waksman R
    Cardiovasc Revasc Med; 2014; 15(8):402-7. PubMed ID: 25499024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.
    Dvir D; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2012; 13(5):281-5. PubMed ID: 22898055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioresorbable scaffolds - nobody is perfect (yet)].
    Alibegovic Zaza J; Zaza S
    Rev Med Suisse; 2015 Mar; 11(464):546, 548-52. PubMed ID: 25924249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US Food and Drug Administration /Conformit Europe- approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves.
    Meek MF; Coert JH
    Ann Plast Surg; 2008 Apr; 60(4):466-72. PubMed ID: 18437784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Commentary.
    Deumens R; Bozkurt A; Brook GA
    Ann Plast Surg; 2010 Sep; 65(3):371. PubMed ID: 20733377
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN transcatheter heart valve for high-risk aortic stenosis patients.
    Barbash IM; Dvir D; Waksman R
    Am Heart J; 2013 May; 165(5):710-5. PubMed ID: 23622907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The past, present, and future of bioresorbable vascular scaffolds.
    Taylor J
    Eur Heart J; 2014 Mar; 35(12):745-6. PubMed ID: 24659189
    [No Abstract]   [Full Text] [Related]  

  • 12. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
    Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the 2013 Food and Drug Administration Circulatory System Devices Panel meeting on the MitraClip Delivery System.
    Minha S; Torguson R; Waksman R
    Circulation; 2013 Aug; 128(8):864-8. PubMed ID: 23960257
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting coronary stent.
    Pinto Slottow TL; Waksman R
    Circulation; 2008 Mar; 117(12):1603-8. PubMed ID: 18362244
    [No Abstract]   [Full Text] [Related]  

  • 15. US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves.
    Meek MF; Coert JH
    Ann Plast Surg; 2008 Jan; 60(1):110-6. PubMed ID: 18281807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health: September 21, 2004.
    Maisel WH;
    Circulation; 2005 Apr; 111(16):2143-5. PubMed ID: 15851621
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIEN™ transcatheter heart valve.
    Barbash IM; Waksman R
    Circulation; 2012 Jan; 125(3):550-5. PubMed ID: 22271848
    [No Abstract]   [Full Text] [Related]  

  • 18. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.
    Pinto Slottow TL; Waksman R
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1064-74. PubMed ID: 17525967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.